Life sciences
-
How COVID-19 has strengthened the value of the UK life sciences industry
The COVID-19 pandemic has put the life sciences industry into the spotlight, the UK is now able to strengthen and grow its position as a global leader. The UK has a remarkable opportunity to further expand its position as a global life sciences hub. Its performance in this sector over the course of the COVID-19 pandemic...
-
Expanding your life science business overseas
The UK BioIndustry Association (BIA) reported recently that the UK’s biotech and life sciences sector is on the cusp of a golden age, driven by strong demand from global investors for UK innovation. We welcome the announcement that the UK government is increasing annual public R&D investment to a record £22 billion by launching an innovation...
-
How Welsh industry is responding to the coronavirus pandemic
Global industries and local businesses in Wales have been adapting and innovating at significant pace and scale in response to COVID-19. The Welsh life sciences sector (including medical technologies, testing, diagnostics and medicine) and businesses beyond have played a significant role in supporting health and social care services across Wales. At the end of March,...
-
Clusters drive global excellence in life sciences
COVID-19 has driven collaboration on an unprecedented scale. Life sciences clusters are at the heart of this and need sustained support to thrive, showcase and drive global excellence. The UK life sciences sector has risen to address the challenges of this extraordinary time by instantly refocussing efforts and resources to tackle the pandemic, with innovation...
-
s Sponsored
Bringing affordable, effective drugs to market quickly
Reformulating existing therapies to better suit patient need can boost outcomes, slash drug development timelines, and facilitate affordable medicine. “Fast-acting insulin, heat stable vaccines, and ready-to-use liquid drug products are just a few examples of how advanced product reformulation techniques are being used to improve outcomes. Approved combinations of advanced excipients can enhance the properties...
-
s Sponsored
Rise in innovation to meet the COVID-19 challenge
Global impact, unprecedented challenges, shifting priorities – these have been hot topics over the recent months. But, a less highlighted topic that should be recognised, is the rapid rate of innovation and commercialisation in the life sciences sector. Reduced production time for new products New products and services have historically taken years to get from...
-
Tackling crises with digital health technologies
Faced with a global crisis, we have seen the best of digital technologies. The challenge now is keeping these advances in place and building on the momentum achieved. The development, implementation and use of digital technologies are based on two key aspects; access to high quality, well curated data sets, and patient ‘buy in’ for...
-
The role of the UK life sciences sector in the race to tackle COVID-19
COVID-19 has disrupted normal life and business planning across the globe. The UK life sciences industry has stepped up at rapid pace to meet this unprecedented challenge. This response has included vaccine development, new testing methods and exploring digital health solutions to tackle the virus. The UK has played a central role in international efforts...
-
Our campaign partners
BioForward 2022 is OBN’s uniquely positioned conference for the life sciences industry providing growing R&D companies with the opportunity to meet and interact with the right industry partners to support them in their plans to build and scale their business and achieve sustainable commercial success All life sciences R&D companies receive a complimentary ticket to...
-
UK Life Sciences are leading the way showcasing world-class innovation
Fast forward to 2050, and the way we live will be completely shaped by the inventions and breakthroughs made today.
Business & Industry